Clinical Trials
All Clinical Trials - Page 38 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT01821846N/ACompleted
Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus
Liraglutide
- NCT01982630Phase 1Completed
Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)
Liraglutide
- NCT01836523Phase 3Completed
The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
Liraglutide
- NCT02001363N/AUnknown
Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury
Liraglutide
- NCT01761318Phase 4Completed
Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
Liraglutide
- NCT01988545N/AUnknown
GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
Exenatide
- NCT03771326Phase 3Completed
KP-10 and Insulin Secretion in Men
Kisspeptin
- NCT01940770N/ACompleted
Specific Clinical Experience Investigation for Long-term Use of Bydureon.
Exenatide
- NCT01979341N/AWithdrawn
The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes
Gonadorelin
- NCT01984320N/ACompleted
Cabergoline and Coasting to Prevent OHSS
Gonadorelin
- NCT01973231Phase 4Completed
Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes
Liraglutide
- NCT01954147Phase 1/Phase 2Unknown
Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus
Liraglutide
- NCT02092597Phase 4Completed
Safety Evaluation of Adverse Reactions in Diabetes
Exenatide
- NCT01952145Phase 3Completed
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
Liraglutide
- NCT01942369N/ACompleted
A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months
Gonadorelin
- NCT01674140Phase 3Active Not Recruiting
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Gonadorelin
- NCT01956851N/ACompleted
Association of Kisspeptin Levels With Insulin Secretion in Diabetes Mellitus
Kisspeptin
- NCT01944488N/AUnknown
LH Response to GnRH Test in Prepubescent Girls Under 6 Years
Gonadorelin
- NCT01926210Phase 4Unknown
Comparison of Ovarian Mild Stimulation and Controlled Ovarian Stimulation in Poor Ovarian Responders
Gonadorelin
- NCT02128334N/ACompleted
An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation
Gonadorelin
- NCT02221999Phase 2/Phase 3Active Not Recruiting
Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients
Gonadorelin
- NCT01928329Phase 2Completed
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Exenatide
- NCT01964170Phase 3Completed
A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer
Gonadorelin
- NCT01921504N/AUnknown
Effect of Acupuncture on Patients With Functional Dyspepsia: a Multi-center, Randomized, Waitlist-controlled Trial
Ghrp-6
- NCT02366247Phase 3Unknown
Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B
Thymosin-Alpha-1
- NCT01762943N/ACompleted
Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition
Gonadorelin
- NCT01916174Phase 1Completed
A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects
Liraglutide
- NCT01890993N/ACompleted
Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe
Liraglutide
- NCT01937598Phase 3Completed
Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D
Liraglutide
- NCT02140983Phase 1Completed
Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes
Liraglutide
- NCT00572689Phase 4Withdrawn
Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
Exenatide
- NCT02040012Phase 1Unknown
A Study to Evaluate AZP531 in Healthy Volunteers, Overweight/Obese Volunteers and Patients With Type 2 Diabetes Mellitus
Ghrp-6
- NCT02055014Phase 4Unknown
Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)
Liraglutide
- NCT01438034Phase 1Completed
Kisspeptin in the Evaluation of Delayed Puberty
Kisspeptin
- NCT02064036Phase 1Completed
Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate
Gonadorelin
- NCT01938820Phase 4Completed
Optimized Treatment and Regression of HBV-induced Early Cirrhosis
Thymosin-Alpha-1
- NCT01943617Phase 4Completed
Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis
Thymosin-Alpha-1
- NCT03050944N/ACompleted
Association of the Mediterranean Diet With Fertility Outcomes
Follistatin
- NCT01934816N/ATerminated
Incretin and KATP Channels
Liraglutide
- NCT01870297Phase 1Completed
A Study of LY3025876 in Participants With Diabetes
Liraglutide
- NCT01857895Phase 1Completed
Feasibility Study of Exenatide by Continuous Subcutaneous Infusion
Exenatide
- NCT01866748Phase 1Completed
Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects
Semaglutide
- NCT02980965Phase 3Completed
Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer
Gonadorelin
- NCT01729676N/ACompleted
Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation
Gonadorelin
- NCT01974544N/AUnknown
Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines
Liraglutide
- NCT01931982Phase 4Completed
Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.
Liraglutide
- NCT01794143Phase 3Completed
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
Liraglutide
- NCT01785771Phase 3Terminated
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
Exenatide
- NCT01455870Phase 3Completed
A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes
Exenatide
- NCT01723774Phase 2Active Not Recruiting
PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Gonadorelin